Showing results (31-40 of 108) with videos related to
Sort By:
Pageof 11
Molecular Cancer Research : MCR|February 11, 2015
Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkersQi Liu, Meng Wang, Ashley M Kern, et al.Molecular Cancer Therapeutics|January 21, 2025
Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer ModelsShan Lu, Xiao Pan, Eva Volckova, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2014
Combined MEK and PI3K inhibition in a mouse model of pancreatic cancerBrinda Alagesan, Gianmarco Contino, Alex R Guimaraes, et al.Oncotarget|November 16, 2017
Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIPAvital Lev, Amriti R Lulla, Jessica Wagner, et al.Cancer Research|January 14, 2016
Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic ResponseAndrew R Conery, Richard C Centore, Kerry L Spillane, et al.Proceedings of the National Academy of Sciences of the United States of America|February 5, 2013
Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patientsBrooke M Emerling, Cyril H Benes, George Poulogiannis, et al.Cancer Research|December 13, 2017
Transcription Factor Activities Enhance Markers of Drug Sensitivity in CancerLuz Garcia-Alonso, Francesco Iorio, Angela Matchan, et al.Nature Communications|November 8, 2022
Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cellsYang Sun, Lu Hu, Zhipeng Tao, et al.Journal of Biomolecular Screening|February 13, 2014
Metadata Standard and Data Exchange Specifications to Describe, Model, and Integrate Complex and Diverse High-Throughput Screening Data from the Library of Integrated Network-based Cellular Signatures (LINCS)Uma D Vempati, Caty Chung, Chris Mader, et al.Science (New York, N.Y.)|January 17, 2015
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitorsRachel Litman Flynn, Kelli E Cox, Maya Jeitany, et al.Pageof 11